Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily eye drops to treat glaucoma, a leading cause of blindness.

Elevated high-density lipoprotein cholesterol (HDL-C) is associated with an increased risk for glaucoma, while elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), and ...

Glenmark Pharmaceuticals launches a generic ophthalmic solution for glaucoma in the US market, adding to its growing ...

Glenmark launches Latanoprost Ophthalmic Solution, targeting $113.5 million market, showcasing commitment to quality eye care ...

It is important to look for specific signs of vision loss in children, and be proactive about routine visits to an eye ...

Patients with varying stages of glaucoma saw no significant difference in outcomes between standard and enhanced monofocal ...

Glaucoma affects vision and mental health, increasing anxiety and depression, which can worsen the disease. Open ...

What started as a ‘friendly conversation’ on the UNTHSC campus could lead to a breakthrough in treating glaucoma—the leading ...

Ophthalmology Times spoke with Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis about how her ...

Inder Paul Singh, MD, speaks to the potential of artificial intelligence (AI) in the management of the glaucoma disease state ...

Too much "good" cholesterol may raise glaucoma risk, while "bad" cholesterol could lower it. Discover the surprising link.

Our brain and eyes can play tricks on us—not least when it comes to the expanding hole illusion. A new computational model ...